4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000068
Chief Medical Officer sold 6,169 shares at $12.99 ($80,135)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-04-09 | Sale | −6,169 | $12.99 | $80,135 | 227,719 | D |
| Open-market sales · 6,169 sh · avg $12.99 · $80,135 | |||||||
Loading xslF345X05/wk-form4_1744402047.xml…